DIVISLAB Divi's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · F&O lot size: 100DIVISLAB lot size: 100 shares per F&O lot for the 3 listed expiries (2026-10-27, 2026-11-23, 2026-12-29). One lot is worth about ₹9.09 lakh at the last underlying price of ₹9,087.01. All F&O lot sizes →
DIVISLAB Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
DIVISLAB Seasonality month by month since 2003 · adjusted month-end closes
DIVISLAB in October: closed the month higher in 15 of 23 years (2003–2025), with a median move of +3.1% and an average of +2.9%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Live setups screens DIVISLAB is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about DIVISLAB
In the last completed session, Divi's Laboratories Ltd. closed -0.54% with futures open interest moving +0.4%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.57, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹9,300 sits 2.3% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Divi's Laboratories Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Divi's Laboratories Ltd. is balanced between accumulation and distribution forces. The next scheduled earnings report is on 2026-10-31, with the consensus EPS estimate at ₹32.23538. Earnings days routinely override positioning signals — keep an eye on the calendar.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
DIVISLAB Option Chain nearest expiry 2026-10-27 · spot 9,087 · EOD 2026-10-19
DIVISLAB option chain today (2026-10-27 expiry, NSE data of 2026-10-19): put-call ratio 0.57 · max pain ₹9,300 · highest call OI at ₹9,500 · highest put OI at ₹8,500 · underlying ₹9,087.01. One lot is 100 shares. At-the-money implied volatility 24.0%, IV rank 33 and IV percentile 52 over the past year (range 17.2%–37.9%); 20-day historical volatility 24.8%.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 34%
Δ 0.99
θ -2.2
ν 0
|
8100 |
IV 34%
Δ -0.01
θ -0.8
ν 0
|
|
IV 34%
Δ 0.98
θ -2.7
ν 1
|
8200 |
IV 34%
Δ -0.02
θ -1.2
ν 1
|
|
IV 30%
Δ 0.98
θ -2.6
ν 1
|
8300 |
IV 30%
Δ -0.02
θ -1.1
ν 1
|
|
IV 30%
Δ 0.97
θ -3.2
ν 1
|
8400 |
IV 30%
Δ -0.03
θ -1.8
ν 1
|
|
IV 29%
Δ 0.94
θ -4.2
ν 2
|
8500 S |
IV 29%
Δ -0.06
θ -2.7
ν 2
|
|
IV 27%
Δ 0.92
θ -4.7
ν 2
|
8600 |
IV 27%
Δ -0.08
θ -3.2
ν 2
|
|
IV 26%
Δ 0.88
θ -5.7
ν 3
|
8700 |
IV 26%
Δ -0.12
θ -4.2
ν 3
|
|
IV 25%
Δ 0.82
θ -6.8
ν 4
|
8800 |
IV 25%
Δ -0.18
θ -5.2
ν 4
|
|
IV 24%
Δ 0.74
θ -7.7
ν 4
|
8900 |
IV 24%
Δ -0.26
θ -6.2
ν 4
|
|
IV 24%
Δ 0.63
θ -8.5
ν 5
|
9000 |
IV 24%
Δ -0.37
θ -6.9
ν 5
|
|
IV 24%
Δ 0.51
θ -8.9
ν 5
|
9100 |
IV 24%
Δ -0.49
θ -7.2
ν 5
|
|
IV 24%
Δ 0.39
θ -8.5
ν 5
|
9200 |
IV 24%
Δ -0.61
θ -6.8
ν 5
|
|
IV 25%
Δ 0.29
θ -7.8
ν 5
|
9300 MP |
IV 25%
Δ -0.71
θ -6.1
ν 5
|
|
IV 26%
Δ 0.21
θ -6.6
ν 4
|
9400 |
IV 26%
Δ -0.79
θ -4.9
ν 4
|
|
IV 27%
Δ 0.15
θ -5.6
ν 3
|
9500 R |
IV 27%
Δ -0.85
θ -3.9
ν 3
|
|
IV 28%
Δ 0.11
θ -4.6
ν 2
|
9600 |
IV 28%
Δ -0.89
θ -2.9
ν 2
|
|
IV 29%
Δ 0.07
θ -3.6
ν 2
|
9700 |
IV 29%
Δ -0.93
θ -1.9
ν 2
|
|
IV 31%
Δ 0.05
θ -2.9
ν 1
|
9800 |
IV 31%
Δ -0.95
θ -1.1
ν 1
|
|
IV 32%
Δ 0.04
θ -2.3
ν 1
|
9900 |
IV 32%
Δ -0.96
θ -0.5
ν 1
|
|
IV 34%
Δ 0.03
θ -2.0
ν 1
|
10000 |
IV 34%
Δ -0.97
θ -0.2
ν 1
|
|
IV 34%
Δ 0.02
θ -1.5
ν 1
|
10100 |
IV 34%
Δ -0.98
θ +0.3
ν 1
|
Chain Interpretation
Strategy Builder multi-leg payoff for DIVISLAB options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
DIVISLAB — frequently asked questions
What is the Divi's Laboratories Ltd. share price today?
DIVISLAB is trading at ₹9,087.00 (-0.63% vs previous close), per the latest update on this page.
What is the P/E ratio of Divi's Laboratories Ltd.?
DIVISLAB (Divi's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 82.5.
What is the market cap of Divi's Laboratories Ltd.?
DIVISLAB has a market capitalisation of approximately ₹241,231 crore.
Is DIVISLAB near its 52-week high?
DIVISLAB is trading -6.7% from its 52-week high of ₹9,740.00 as of 2026-10-19.
What is the RSI of DIVISLAB?
The 14-day RSI of DIVISLAB is 44.7, which is considered neutral.
Is DIVISLAB above its 200-day moving average?
DIVISLAB is trading above its 200-DMA of ₹7,229.25 (+25.7% away).
What is the F&O buildup in DIVISLAB?
The latest end-of-day derivatives data classifies DIVISLAB as Neutral (bias: neutral), based on the day's combined price and open-interest change.
What is the max pain and PCR for DIVISLAB options?
DIVISLAB's option-chain max pain strike is ₹9,300 and its put-call ratio (OI) is 0.57, from the latest end-of-day option chain.
Are FIIs or big investors buying DIVISLAB?
Strota tracks every bulk and block deal in DIVISLAB with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.